Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optic neuritis and early treatment with methylprednisolone
2012-002628-34Phase 4Completed
- Sponsor
- Thor Petersen
- Start
- Jul 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylprednisolone in optic neuritis (ON), sponsored by Thor Petersen. Primary endpoint: Retinal nerve fiber layer thickness. Started Jul 2012; status: completed.
02
Drugs
methylprednisolone
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on 2012-002628-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002628-34.